Evidence map›Paper›PMID 39528231›Full record

ArticleOrganic letters2024

Improved

Dhrubajyoti Datta, Pawan Kumar, Jayanta Kundu, June Qin, Jason A Gilbert, Sally Schofield, Daniel P Donnelly, Ju Liu, Rohan Degaonkar, Martin Egli and 1 more

Abstract read
In one paragraph

Article in Organic letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dhrubajyoti DattaAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Pawan KumarAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Jayanta KunduAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
June QinAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Jason A GilbertAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Sally SchofieldAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Daniel P DonnellyAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Ju LiuAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.ORCID 0000-0003-1030-9266
Rohan DegaonkarAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.
Martin EgliDepartment of Biochemistry, Vanderbilt University, School of Medicine, Nashville, Tennessee 37232, United States.ORCID 0000-0003-4145-356X
Muthiah ManoharanAlnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, Massachusetts 02142, United States.ORCID 0000-0002-7931-1172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To ensure specificity, loading of the sense strand of small interfering RNAs (siRNAs) into RISC must be inhibited. We show here that siRNAs with 5'- and 6'-morpholino LNA residues or 6'-OH-LNA at the 5' terminus of a fully phosphodiester sense strand resulted in metabolically stable siRNAs with a potency and a duration of action in mice that were greater than those of an siRNA in which the 5' terminus of the sense strand has two terminal phosphorothioate linkages and regular LNA.

Indexed as

AcetylgalactosamineMorpholinosOligonucleotidesRNA, Small InterferingAnimalsGene SilencingMiceMolecular StructureAcetylgalactosaminelocked nucleic acidMorpholinosOligonucleotidesRNA, Small Interfering

Identifiers

PMID39528231
PMCPMC11613684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.